pharmaphorum

MARCH 3, 2022

DarioHealth has beefed up its sales and marketing channels as well as its range of digital health products thanks to a $30 million strategic alliance with drugmaker Sanofi. Erez Raphael.

Behavioural Health 91

Behavioural Health Sales Marketing Clinical Trials 91

pharmaphorum

JANUARY 26, 2021

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. Clinical trials get more and more digitalised. Consolidation of digital health platforms. Aging in place’ becomes more commonplace.

Clinical Trials 141

Clinical Trials Clinical Trials Sales Life Science 141

pharmaphorum

APRIL 25, 2022

Gani started BehaVR in 2016 to create DTx for mental and behavioural health. He says after a meeting between him and a leader at Sumitomo in 2018 or 2019, it became apparent both companies believed in the power of VR in mental health care. They also understand how to do clinical trial design,” Gani states.

Behavioural Health 105

Behavioural Health Production Clinical Trials Clinical Trials 105

pharmaphorum

APRIL 23, 2021

The company has been pushing for more reimbursement of its three marketed DTx products in the US following a first FDA approval in 2017. Pear noted that the grant comes at a time when many communities are seeing increased demand for behavioural health and recovery services amid the ongoing coronavirus pandemic.

FDA Approval 64

FDA Approval Behavioural Health Clinical Trials Clinical Trials 64

pharmaphorum

JANUARY 27, 2022

Immersive technology can also help improve assessments of the effectiveness of treatment, particularly regarding behavioural health where a patient’s results are often subjective. For example, mental health disorders and cognitive decline are rising.

Production 142

Production Development Behavioural Health Research 142

pharmaphorum

APRIL 6, 2021

In a clinical trial, the software was found to be accurate to within three beats per minute for pulse rate compared to contact pulse oximeters, and two breaths per minute for estimated breathing rate. The approval means the Oxford University spin-out can place Oxevision on the market in all US states.

Nurses 59

Nurses Behavioural Health FDA Approval Clinical Trials 59

pharmaphorum

DECEMBER 16, 2022

Digital therapeutics company Cognoa, which focuses on paediatric behavioural health, announced the appointment of Dr Sharief Taraman as its new CEO. Clinical trials technology company Saama has hired Dr Clinton White as its new chief delivery officer. We’ve rounded up some highlights below. Digital therapeutics hires.

Behavioural Health 52

Behavioural Health Reagent Gene Therapy Production 52